- pause slideshow
Final details about the £170m community pharmacy cuts, which were expected to be announced in July 2016, have been delayed, possibly until after October 2016, The Pharmaceutical Journal has learnt.
The European Medicines Agency (EMA) has launched a public consultation on proposals to change its guidance on first in human (FIH) clinical trials.
As a clinical research pharmacist in a GP practice, Andrew Sturrock’s first project will be looking at the development of diabetes.
How to spot signs of child sexual exploitationVideoSubscription
Children and young people affected by sexual exploitation can present to a wide range of health settings, including community pharmacies. Pharmacists should be aware of the signs of potential sexual exploitation to ensure that they seek the appropriate help and support to protect the child or young person.
Abstract Long-term (five years) adjuvant tamoxifen treatment for oestrogen receptor-positive, or ER-positive, breast cancer post-surgery is recognised as a major advance in healthcare. Clinical trials comparing standard and extended tamoxifen therapy found a major decrease in mortality occurred in the ten years following a decade of adjuvant therapy. Studies in premenopausal breast cancer patients showed that ovarian function suppression (OFS) plus an aromatase ...
If the healthcare industry is to move forward over the next 20 years, the culture of blame needs to change to encourage healthcare professionals to report errors so that others can learn from them.
Healthcare students at the University of Manchester have set up a society to improve inter-professional learning. Pharmacy student Linda Owens describes its most popular event, the clinical skills evening.
Five years after the new incarnation of the Royal Pharmaceutical Society, it may be time to review its governance structure.
Since the discovery of omeprazole in 1979, dispensing of proton pump inhibitors (PPIs) in England has increased more than 100-fold, and several products are now available without prescription. Although PPIs are effective and generally well tolerated, observational studies suggest an association with several adverse effects. Further trials are needed to establish causal relationships.
From 1 August 2016, the 40th edition of ‘Medicines, Ethics and Practice’, which includes a number of amendments and additions, will be available on the Royal Pharmaceutical Society website and in the July 2016 issue of The Pharmaceutical Journal.
Defined as the non-inducible recurrence of wheals, angioedema or both for six weeks or more, chronic spontaneous urticaria is a difficult to diagnose and debilitating skin condition. Pharmacists should be aware of the clinical features in order to identify and manage this condition effectively.
How antiphospholipid syndrome, also known as Hughes syndrome, is diagnosed and the appropriate therapeutic options for its management.
Ever dreamt of upping sticks and making the move elsewhere? Perhaps to the coast, a pretty village, or maybe to the heart of an exciting, fast-paced city?
The 2016 I Love My Pharmacist Award was launched on 18 April 2016. For the first time in the three-year history of the award, members of the public could nominate their favourite pharmacist. At the beginning of June the finalists in each region were announced and now the public has until 21 July 2016 to vote for their favourite. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion. This year The Pharmaceutical Journal is the media partner of I Love My Pharmacist, on our special report page you can see all of our content around the Award and find out more about the candidates in the running this year.
Chronic fatigue syndrome, or myalgic encephalomyelitis, has been largely dismissed as psychological. But recent trials of antiviral and immunosuppressant drugs have yielded encouraging results, suggesting a complex disease mechanism at play that researchers are hopeful they might be able to treat.
Some athletes are willing to take huge risks by using drugs to gain a competitive advantage. But anti-doping scientists are working hard to improve detection methods and develop new strategies to ensure a fair competition and to protect athletes’ health.
The Pharmaceutical Journal's panel discussion: Medicines, innovation and the value of medicineSubscription
Key opinion leaders were brought together to debate the controversial topic of highly priced medicines at The Pharmaceutical Journal’s panel discussion on 14 September 2015 at the Royal Pharmaceutical Society’s annual conference in Birmingham.
Pharmacy at home: service for frail older patients demonstrates medicines risk reduction and admission avoidanceSubscription
The Exeter Cluster Pharmacy (ECP) team is part of an integrated community health and social care service, providing domiciliary medicines optimisation to around 145,000 people. The service undertakes clinical medication reviews for frail older people at home, assessing their risk of medicine-related harm in order to reduce these risks and potentially prevent hospital admissions. Objective: An evaluation was completed in 2014 to assess the level of service ...
Medicines shortage management survey Subscription
Release details of how each member votedSubscription
President should be elected by membersSubscription